Jens Voortman

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Skeletal Muscle

Top Venues

Nature communications

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Anouk W M A Schaeffers, Lot A Devriese, Carla H van Gils, Jan Willem Dankbaar, Jens Voortman, Jan Paul de Boer, Marije Slingerland, Mathijs P Hendriks, Ernst J Smid, Geert W J Frederix, Remco de Bree
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol. PloS one 18 (11) (2023)
Wittaya Panvongsa, D Michiel Pegtel, Jens Voortman
More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma. Cancers 14 (5) (2022)
Jonathan Wade Goldman, Sarina A Piha-Paul, Brendan D Curti, Katrina S Pedersen, Todd M Bauer, Stefanie L Groenland, Richard D Carvajal, Vaishali Chhaya, Gray Kirby, Kelly McGlinchey, Scott A Hammond, Katie Streicher, Danielle M Townsley, Young Kwang Chae, Jens Voortman, Aurélien Marabelle, John D Powderly
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Maud Rijnders, Hayri E Balcioglu, Debbie G J Robbrecht, Astrid A M Oostvogels, Rebecca Wijers, Maureen J B Aarts, Paul Hamberg, G J L H Geert van Leenders, José Alberto Nakauma-González, Jens Voortman, Hans M Westgeest, Joost L Boormans, Ronald de Wit, Martijn Paul Lolkema, Astrid A M van der Veldt, Reno Debets
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)